Tolterodine for Symptoms Associated With Overactive Bladder: A Nighttime Dosing Regimen Maintains Efficacy and Improves Tolerability
Mattiasson A 1, de Wit E J2, Kirby S2 1. Lund University Hospital, 2. Pfizer Inc
|
|
Abstract 391
|
|
|
Read By Title:
Scientific Non Discussion Abstract Session 21
|
|
|